a PDF version of the Full Hematology Oncology Curriculum

Specific Program Content
The Fellows receive formal instruction, clinical experience, and opportunities to acquire knowledge in
the following:
1. Morphology, physiology, and biochemistry of blood, marrow, lymphatic tissue, and the spleen
2. Basic molecular and pathophysiologic mechanisms, diagnosis, and therapy of diseases of the
blood, including anemias, diseases of white cells, and disorders of hemostasis and thrombosis
3. Etiology, epidemiology, natural history, diagnosis, pathology, staging, and management of
neoplastic disorders
4. Immune markers, immunophenotyping, cytochemical studies, and cytogenetic and DNA analysis
of neoplastic disorders
5. Molecular mechanisms of neoplasia, including the nature of oncogenes and their products
6. Chemotherapeutic drugs, biologic products, and growth factors and their mechanisms of action,
pharmacokinetics, clinical indications, and limitations, including their effects, toxicity, and
interactions
7. Multiagent chemotherapy protocols and combined modality therapy in the treatment of
neoplastic disorders
8. Principles and application of surgery and radiation therapy in the treatment of neoplastic
disorders
9. Management of the neutropenic and/or immunocompromised patient
10. Effects of systemic disorders, infections, solid tumors, and drugs on the blood, blood‐forming
organs, and lymphatic tissues
11. Allogeneic and autologous bone marrow transplantation and the nature and management of
post‐transplant complications
12. Indications and application of imaging techniques in patients with blood and neoplastic
disorders
13. Pathophysiology and patterns of solid tumor metastases
14. Principles of gynecologic oncology
15. Pain management in the cancer patient
16. Rehabilitation and psychosocial management of patients with hematologic and neoplastic
disorders
17. Hospice and home care for the cancer patient
18. Recognition and management of paraneoplastic disorders
19. The etiology of cancer, including predisposing causal factors leading to neoplasia
20. Cancer prevention and screening
21. Leading an active multidisciplinary tumor board
22. Tests of hemostasis and thrombosis for both congenital and acquired disorders and regulation
of antithrombotic therapy
23. Treatment of patients with disorders of hemostasis and the biochemistry and pharmacology of
coagulation factor replacement
24. Transfusion medicine, including the evaluation of antibodies, blood compatibility, and the use of
blood component therapy and apheresis procedures
25. Personal development, attitudes, and coping skills of physicians and other health‐care
professionals who care for critically ill patients
26. Human immunodeficiency virus‐related and other immunodeficient states associated
malignancies
16